A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

NCT05798819 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

424

Enrollment

INDUSTRY

Sponsor class

Conditions

Persistent, Recurrent, or Metastatic Cervical Cancer

Interventions

DRUG: GLS-010
DRUG: Placebo
DRUG: paclitaxel
DRUG: cisplatin
DRUG: carboplatin
DRUG: bevacizumab

Sponsor

Guangzhou Gloria Biosciences Co., Ltd.